The RTOP is based on a technology transfer strategy in which Alliance researchers participate in a two-stage training process.
- Stage 1, the Alliance will fund one visit per year by an eligible PR Alliance investigator to travel to a host laboratory within a U.S. institution that has developed and standardized the desired emerging technology. The investigators will establish a relationship with the PI at the hosting laboratory and will learn how to implement the specific methodology in PR.
- Stage 2, will consist of a visit to PR of the host PI to continue with the implementation of the technology within the PR Alliance institution by providing scientific expertise.
These are the RTOP 2021 Awardees that will receive $5,000 each
Catherine Chacin, DDS, MPH
Salivary Inflammation Profile of Hispanic Infants
Project description: The proposed project will allow us to perform a salivary inflammation profile to observe the specific characteristics of infants at higher risk of obesity to perhaps enhance our capacity to predict the life-long risk of the disease and associated comorbidities.
Ailed M. Cruz Collazo, PhD
Rac/Cdc42 inhibitors as new drugs for pancreatic cancer
Project description: Demonstrate the efficacy of Rac/Cdc42 inhibitors as new drugs for pancreatic cancer using pancreatic cancer mouse models, and the effect on tumor microenvironment from pancreatic cancer patient’s tissue.
